# Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients

> **NCT04880382** · PHASE2 · TERMINATED · sponsor: **Institut Bergonié** · enrollment: 8 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** ICI treatment discontinuation
- **DRUG:** ICI treatment continuation

## Key facts

- **NCT ID:** NCT04880382
- **Lead sponsor:** Institut Bergonié
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-27
- **Primary completion:** 2026-02-23
- **Final completion:** 2026-02-23
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Enrolment was slowlier than expected.
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04880382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04880382, "Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04880382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*